Type I BREX system defends against antibiotic-resistant plasmids in <i>Escherichia coli</i>
Xiaoying Jiang(Hangzhou Normal University), Minggui Wang(Fudan University), Zhewei Sun(Fudan University), Wanzhen Li(Tongji University), Yuan Yuan(Fujian Agriculture and Forestry University), Dan Li(Fudan University), Pei Li(Fudan University), Dongliang Wang(Hebei Medical University), Yanyan Lu(Fudan University), Lianhua Wei(Gansu Provincial Hospital), Xiaogang Xu(Fudan University)
Cited by 4
Related Papers
Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study
|The Lancet Infectious Diseases|2021|338
Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study
|The Lancet Infectious Diseases|2020|328
Emerging Plasmid-Mediated Quinolone Resistance Associated with the <i>qnr</i> Gene in <i>Klebsiella pneumoniae</i> Clinical Isolates in the United States
|Antimicrobial Agents and Chemotherapy|2004|239
Natural terpenoids with anti-inflammatory activities: Potential leads for anti-inflammatory drug discovery
|Bioorganic Chemistry|2022|172
Functionalized quinoxalinones as privileged structures with broad-ranging pharmacological activities
|European Journal of Medicinal Chemistry|2022|105